Cargando…
APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death
Genomic, transcriptional, and proteomic analyses of brain tumors reveal that subtypes differ in their pathway activity, progression, and response to therapy. We performed an expression profiling of Glioma Initiating Cells (GICs) and comparative analysis between different groups of GICs indicates maj...
Autores principales: | Wang, Yu, Wu, Shaofang, Zheng, Siyuan, Wang, Shuzhen, Wali, Arjun, Ezhilarasan, Ravesanker, Sulman, Erik P., Koul, Dimpy, Alfred Yung, W.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589580/ https://www.ncbi.nlm.nih.gov/pubmed/28903341 http://dx.doi.org/10.18632/oncotarget.17348 |
Ejemplares similares
-
Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma
por: Koul, Dimpy, et al.
Publicado: (2017) -
The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells
por: Dong, Jianwen, et al.
Publicado: (2018) -
DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas
por: Yang, Jie, et al.
Publicado: (2022) -
Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation
por: Noureen, Nighat, et al.
Publicado: (2021) -
Identification of patient-derived glioblastoma stem cell (GSC) lines with the alternative lengthening of telomeres phenotype
por: Farooqi, Ahsan, et al.
Publicado: (2019)